Skip to main content

Currently Skimming:

Appendix C: Speaker Biographical Sketches
Pages 85-96

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 85...
... Dr. Ahmedani conducts research in the domains of health services and interventions, health disparities, and precision medicine.
From page 86...
... She provides continuing medical education on cancer screening and hereditary cancer syndromes for medical staff, residents, and medical students and oversees a patient navigator program to increase breast and colo­ rectal cancer screening and Pap testing in refugee and minority patients.
From page 87...
... Otis Brawley, M.D., MACP, FASCO, FACE, is the chief medical and scientific officer for the American Cancer Society and, as such, is responsible for promoting the goals of cancer prevention, early detection, and quality treatment through cancer research and education. He champions efforts to decrease smoking, improve diet, and provide the critical support cancer patients need.
From page 88...
... From April 2001 to November 2007 he was the director of the Georgia Cancer Center at Grady Memorial Hospital in Atlanta and the deputy director for cancer control at the Winship Cancer Institute at Emory University. He filled a variety of capacities at the National Cancer Institute, most recently serving as an assistant director.
From page 89...
... Dr. Hoskins's National Cancer Institute–funded research focuses on breast cancer risk assessment as a strategy for addressing cancer health disparities and involves both population science and molecular approaches to
From page 90...
... He is pursuing several avenues of research to address these issues, including molecular epidemiologic ­ tudies, s tumor genomic and molecular biologic studies, preclinical studies with novel agents, and drug discovery efforts. Finally, his work also involves research to understand the ethical, psychosocial, and behavioral issues accompanying precision medicine and individualized cancer risk prediction in minority women, especially as it pertains to the use of genomic technologies.
From page 91...
... Laurence Meyer, M.D., Ph.D., is the chief officer of specialty care services and the national director of genomic medicine for the Veterans Health Administration (VHA)
From page 92...
... Her current breast cancer research is the second study at the intersection of precision medicine and cancer disparities, exploring communication related to hereditary breast and ovarian cancer in three public hospitals. In her role as the director of the UCSF Helen Diller F ­ amily Comprehensive Cancer Center Office of Community Engagement, she established a faith communities partnership in four Bay Area counties that fosters and sustains health ministries in African American churches through various service and research programs designed to build their capacity to promote health.
From page 93...
... The goal of the study is to identify and overcome the barriers to using pharmacogenomics to guide clinical drug therapy. The implementation studies include prospectively testing and using pharmacogenetic testing in clinical care.
From page 94...
... Dr. Taylor's work focuses on the interaction of omics and social factors that contribute to health disparities for common chronic conditions among underrepresented minority populations in the United States and vulnerable populations abroad.
From page 95...
... Dr. Tuckson is a graduate of Howard University, the Georgetown University School of Medicine, and the Hospital of the University of P ­ ennsylvania's general internal medicine residency and fellowship programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.